Compared to Q2 2023, we have decreased our operating expenses by more than $600 million in Q2 2024. This reduction highlights our commitment to operational efficiency and financial discipline.

Analysts estimate EPS of $4.55 vs. $6.46 in Q2 FY 2021. Revenue is expected to grow at a slower rate as global pandemic eases. On July 29, Moderna received a U.S. government order for 66 million ...

Moderna’s financial results for the second quarter of 2024 reveal a mixed bag of outcomes. The company reported total revenue of $241 million, down from $344 million in the same period last year ...

Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue ...

Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for its marketed products and low sales in the EU.

Moderna will announce Q2 2024 earnings this Thursday, 1st August. Moderna stock hit highs of $450 per share in late 2021, but has since seen a decrease ~$120, and a current market cap valuation of ...

Moderna (MRNA) came out with a quarterly loss of $3.33 per share versus the Zacks Consensus Estimate of a loss of $3.47. This compares to loss of $3.62 per share a year ago. These figures are ...

Analysts expect Moderna's strong financial performance to continue in Q2 FY 2021. The company is expected to post its second quarter of profitability, with EPS predicted to more than double from ...

Moderna Inc. (NASDAQ:MRNA) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ETCompany ParticipantsStéphane Bancel - Chief Executive OfficerStephen ...